APR Applied Pharma Research s.a. Revenue and Competitors

Balerna,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • APR Applied Pharma Research s.a.'s estimated annual revenue is currently $11.9M per year.(i)
  • APR Applied Pharma Research s.a.'s estimated revenue per employee is $201,000

Employee Data

  • APR Applied Pharma Research s.a. has 59 Employees.(i)
  • APR Applied Pharma Research s.a. grew their employee count by -8% last year.

APR Applied Pharma Research s.a.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is APR Applied Pharma Research s.a.?

APR is a Swiss independent pharma company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases. APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management. A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases. Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$11.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

APR Applied Pharma Research s.a. News

2022-04-19 - Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil

... reported today that the parent company, NRx Pharmaceuticals, ... Relief's acquisitions last summer of APR Applied Pharma Research SA and...

2022-03-30 - Relief Therapeutics Reports In Vivo Data Indicating Prolonged ...

... Data In Animal Models Suggest That APR's Controlled Release Amino ... APR Applied Pharma Research SA ("APR"), reported data published in...

2022-03-22 - Relief Therapeutics' Wholly Owned Subsidiary, APR Applied ...

Finally, Relief's acquisitions of APR Applied Pharma Research SA and AdVita Lifescience GmbH, brought to Relief a diverse pipeline of marketed...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.1M916%N/A